Does Boston Scientific (BSX) Have the Potential to Rally 25.61% as Wall Street Analysts Expect?

Core Viewpoint - Boston Scientific (BSX) shares have increased by 3% recently, closing at $101.11, with analysts suggesting a potential upside of 25.6% based on a mean price target of $127 [1] Price Targets and Analyst Consensus - The average price target consists of 31 estimates, ranging from a low of $113.00 to a high of $140.00, with a standard deviation of $6.38, indicating a relatively high agreement among analysts [2] - The lowest estimate suggests an 11.8% increase, while the highest indicates a 38.5% upside [2] - A low standard deviation signifies strong consensus among analysts regarding BSX's price movement [9] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about BSX's earnings prospects, as evidenced by a positive trend in earnings estimate revisions [11] - Over the past 30 days, the Zacks Consensus Estimate for the current year has risen by 2%, with 10 estimates moving higher and no negative revisions [12] - BSX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Implications of Price Targets - While the consensus price target may not be a reliable predictor of BSX's potential gains, the direction indicated by these targets appears to be a useful guide for further research [14]